NIH-supported research spanning decades helped pave the way for new treatment options for people living with fibrodysplasia ossificans progressiva (FOP), an ulta-rare and devastating genetic disease.
Read more:
NIH researchers examined immune responses in 45 healthy adults and identified key immune markers associated with protection and increased risk during a second dengue infection.
Learn more about this important advance in dengue research:
National Institutes of Health (NIH) researchers demonstrated that tracking physical activity over a full year revealed almost twice as many disease risk factors as the one-week snapshots typically obtained by wearable studies.
Read more:
Synthetic PFAS chemicals persist throughout the environment and in our bodies. NIH-funded research found a new and potentially safer, low-energy method of converting PFAS into harmless byproducts.
Read more:
New NIH-supported research sheds light on cellular changes that occur before the disease develops, offering important clues that could help researchers identify future targets for prevention and treatment.
Learn more:
👁️ Good news for corneal transplant patients: An NIH-funded study found that donor diabetes severity was not linked to transplant outcomes one year after surgery.
Learn more:
NIH researchers have discovered a natural defense mechanism that may help the body prevent plaque from building up inside arteries, opening new possibilities for treating atherosclerotic cardiovascular disease, a leading cause of death in the U.S.
How does environmental pollution affect fetal development?
NIH-supported researchers created a placenta-on-a-chip to find out.
New research supported by NIH shows that personalized alerts about flu risk can make a real difference.
In a large NIH-supported study, scientists have developed a blood-based lab test that can accurately detect early-stage pancreatic ductal adenocarcinoma (PDAC), one of the deadliest forms of cancer.
Learn more:
